Item 1. Security and Issuer
This Amended Statement of Beneficial Ownership on Schedule 13D (“Amendment 4”) amends and supplements the Statement of Beneficial Ownership on Schedule 13D filed by Fengate Trident LP, Fengate Trident GP Inc., and Fengate Capital Management Ltd. (collectively, the “Reporting Persons”) on May 8, 2017 (the “Initial Schedule 13D”), the Amended Schedule 13D filed by the Reporting Persons on September 14, 2017 (“Amendment 1”), the Amended Schedule 13D filed by the Reporting Persons on September 18, 2017 (“Amendment 2”) and the Amended Schedule 13D filed by the Reporting Persons on November 5, 2019 (“Amendment 3”) in connection with the parties and matters referenced therein and herein, with respect to the Common Stock, $.001 par value (the “Common Stock”) of Trident Brands, Inc. (the “Issuer”). This Schedule 13D is being filed as a result of the events described in Item 4 below. Any capitalized terms used and not defined in this Amendment 4 shall have the meanings set forth in the Initial Schedule 13D, Amendment 1, Amendment 2 and/or Amendment 3. Only those items that are hereby reported are amended; all other items, including previously filed exhibits, remain unchanged and are incorporated by reference herein.
Item 3. Source and Amount of Funds or Other Consideration
The Common Stock reported in this Amendment 4 includes 2,811,886.44 shares of Common Stock beneficially owned by the Reporting Persons and additional shares of Common Stock that may be issued to the Reporting Persons upon conversion of certain Convertible Notes, as defined below. As of November 6, 2019, the Reporting Persons had acquired from the Issuer Convertible Notes in an aggregate principal amount of $22,300,000 and the total accrued but unpaid interest on such Convertible Notes was $3,035,217. None of the shares of Common Stock or Convertible Notes were acquired on margin, or otherwise using borrowed funds or pursuant to any loan or credit arrangement.
Item 4. Purpose of Transaction
The Common Stock and Convertible Notes have been acquired for investment purposes in the ordinary course of the Reporting Persons’ investment activities, and have not been acquired with any purpose of, or with the effect of, changing or influencing the control of the Issuer, or in connection with or as a participant in any transaction having such purpose or effect. From time to time the Reporting Persons may acquire additional securities of the Issuer, or sell securities of the Issuer. In addition to the transactions reported in the Initial Schedule 13D, Amendment 1, Amendment 2 and Amendment 3, the following transactions have occurred:
On November 6, 2019, pursuant to the SPAA (as defined in Amendment 3), the Reporting Persons purchased from the Issuer Additional Convertible Notes (as defined in Amendment 3) in the amount of $3,795,033, convertible into 20,331,176shares of Common Stock and the parties agreed to extend the maturity date by one month to June 30, 2020. As a result, the Reporting Persons beneficially own 67,823,219.44 shares of Common Stock, held in the form of 2,811,866.44 shares of Common Stock and Convertible Notes which, as of November 6, 2019, were convertible into 65,011,353shares of Common Stock, constituting 69.7%percent of the class of Common Stock (based on the Issuer’s Form 10Q dated October 21, 2019).
As of the date of this Amendment 4, the Reporting Persons have no plans or proposals which relate to or would result in (i) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (ii) a sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (iii) any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (iv) any material change in the present capitalization or dividend policy of the issuer; (v) any other material change in the issuer’s business or corporate structure; (vi) changes in the issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (vii) causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (viii) a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (ix) any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer
(a)-(b) | Incorporated by reference to Items (7) - (11) and (13) of the cover page relating to each Reporting Person, and the disclosure in Item 4. |
(c) | Other than as reported herein, in the sixty days prior to the date of filing of this Amendment 4, the Reporting Persons have engaged in no other transactions in the Issuer’s Common Stock. |
(d) | Except as set forth herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities of the Issuer reported on in this Amendment 4. |